Egypt and Bolivia expressed interest in buying JF-17 Thunder Block 3 aircraft
Pakistan Air Force plans to induct more than 50 JF-17 Thunder Block 3 into the fleet. Pakistan Air Force currently operates more than 135 JF-17 Thunder aircraft.

ISLAMABAD: Egypt and Bolivia have expressed interest in buying JF-17 Thunder Block 3 aircraft.
The demand for Pakistani fighter jet JF-17 Thunder started to increase. According to sources, Egypt and Bolivia have expressed interest in buying JF-17 Thunder Block 3 aircraft.
Argentina, Iraq, Azerbaijan and others are also looking to buy these advanced fighter jets. Next year, the number of JF-17 Thunder aircraft in the world will increase to 200. Currently, more than 150 JF-17 Thunder aircraft are in use by Pakistan, Myanmar and Nigeria.
The Block 3 version of the fighter jet is equipped with advanced radars, digital systems, advanced avionics, lethal weapons. The JF-17 Thunder is the $15 to $25 million cheapest multi-role fighter jet for the developing world.
Pakistan Air Force plans to induct more than 50 JF-17 Thunder Block 3 into the fleet. Pakistan Air Force currently operates more than 135 JF-17 Thunder aircraft.

PM Shehbaz signs ‘Gaza Board of Peace’ draft at Davos
- an hour ago
Israeli strike kills three Gaza journalists including AFP freelancer
- 19 hours ago
China completes first-phase 6G trials
- 21 hours ago
Eight Arab, Islamic states announce to join Board of Peace: FO
- 19 hours ago

Gold prices set another historic record in Pakistan
- 21 hours ago

An exclusive look inside the largest effort ever mounted to keep the Great Barrier Reef alive
- 2 hours ago

Trump and Greenland: Latest stories and updates
- 11 hours ago

Trump is waffling on Iran strikes. Here are four possible reasons why.
- 11 hours ago

Microsoft’s first Windows 11 update of 2026 stopped some computers from shuting down
- 13 hours ago
.jpg&w=3840&q=75)
PM meets world leaders during WEF meeting
- an hour ago

Ricoh’s black-and-white-only camera launches in February for $2,200
- 13 hours ago

One weird thing that’s been holding drug trials back
- 11 hours ago




